financetom
Business
financetom
/
Business
/
BMO Looks at Correlation Between U.S. Tariffs and Canada's Home Prices
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BMO Looks at Correlation Between U.S. Tariffs and Canada's Home Prices
Jul 29, 2025 4:36 AM

07:16 AM EDT, 07/29/2025 (MT Newswires) -- Since January, home prices have fallen 6% in Ontario, one of the two provinces in Canada most impacted by United States tariffs, said Bank of Montreal (BMO).

The declines have been widespread, including a 5% dip in the largest region, Greater Toronto, noted the bank.

However, there is no clear evidence, yet, that tariffs are disproportionately affecting two auto-led cities, Windsor and Oshawa (Durham Region), and only slim evidence of an impact on steel-town Hamilton, where prices are off 7%, stated BMO.

Alas, if current hefty duties persist, layoffs in both

industries and the resulting impact on housing markets in these cities could mount, added the bank.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Revelation Biosciences Completes Dosing for Phase 1b Trial of Gemini for Chronic Kidney Disease
Revelation Biosciences Completes Dosing for Phase 1b Trial of Gemini for Chronic Kidney Disease
Jul 16, 2025
10:41 AM EDT, 07/16/2025 (MT Newswires) -- Revelation Biosciences ( REVB ) said Wednesday it completed dosing for an escalating-dose phase 1b trial of intravenously-administered Gemini in people with stage 3 and 4 chronic kidney disease. The company said that, as planned, five groups were enrolled at three clinics in the US, and trial data sets are expected in Q3....
MBX Biosciences' Hypoparathyroidism Treatment a 'Key Catalyst,' Oppenheimer Says
MBX Biosciences' Hypoparathyroidism Treatment a 'Key Catalyst,' Oppenheimer Says
Jul 16, 2025
10:43 AM EDT, 07/16/2025 (MT Newswires) -- MBX Biosciences' ( MBX ) hypoparathyroidism drug, canvuparatide, is a key catalyst for the company as its potentially favorable efficacy to current treatments could be a $2 billion global peak sales opportunity, said Oppenheimer said in a Wednesday note. Oppenheimer said its enthusiasm for MBX Biosciences ( MBX ) stems from the company's...
Goldman Sachs' Results Top Views on Equity Trading, Investment Banking Gains
Goldman Sachs' Results Top Views on Equity Trading, Investment Banking Gains
Jul 16, 2025
10:44 AM EDT, 07/16/2025 (MT Newswires) -- Goldman Sachs ( GS ) logged stronger-than-expected second-quarter results, buoyed by record equity trading revenue and a surge in investment banking gains. Per-share earnings rose to $10.91 from $8.62 a year earlier, above the FactSet-polled consensus estimate of $9.65. Revenue jumped 15% annually to $14.58 billion, while analysts projected $13.51 billion. At this...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved